$ARE

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Alexandria Real Estate Equities is a real estate investment trust that owns, operates, and develops laboratory and other properties for life science, technology, and research organizations. Its tenants include pharmaceutical and biotechnology companies, life science product and service providers, medical device and digital health companies, academic and medical research institutions, government research agencies, nonprofits, and venture capital firms. Alexandria also provides strategic capital to life science companies and invests in publicly traded and privately held entities, primarily in the life science industry. Its properties are organized around geographic markets including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, New York City, and Texas. Alexandria earns rental income by leasing properties and develops or redevelops space for tenants, including converting acquired office, warehouse, or shell space into laboratory facilities. The company is headquartered in Pasadena, California.

0
3
3

No SEC Form 4 filings for $ARE in the last 30 days.

See all $ARE insider activity →

Alexandria Real Estate adds dual listing on NYSE Texas

Alexandria Real Estate Equities (NYSE: ARE) will add a dual listing on NYSE Texas, maintaining its primary listing on the NYSE. The company operates life science properties in Texas, including a campus in Greater Houston and a facility in Austin. Alexandria Venture Investments, its venture capital arm, has invested in Texas-based CrossBridge Bio, which is set to be acquired by Eli Lilly for up to $300 million.

BofA downgrades Alexandria Real Estate stock rating on earnings concerns

BofA Securities downgraded Alexandria Real Estate Equities (NYSE:ARE) to Underperform, lowering its price target to $45 from $55. The company reported a $8.40 per share loss and 9.77% revenue decline over the last year, despite a 6.5% dividend yield. BofA cited declining earnings and leasing challenges as reasons for the downgrade. Alexandria's Q3 2026 results showed mixed performance, with revenue exceeding estimates but significant earnings loss due to real estate impairments.

ARE sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 6 news stories mentioning ARE (ALEXANDRIA REAL ESTATE EQUITIES, INC.). Coverage has skewed bearish: 0 bullish, 3 neutral, and 3 bearish.

Recent ARE coverage spans earnings, financial news and corporate actions.

What's driving ARE

AlphAI scores every news story that mentions ARE with an AI model for sentiment and relevance, and aggregates insider trades from ALEXANDRIA REAL ESTATE EQUITIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ARE

Score

Alexandria Real Estate adds dual listing on NYSE Texas

Alexandria Real Estate Equities (NYSE: ARE) will add a dual listing on NYSE Texas, maintaining its primary listing on the NYSE. The company operates life science properties in Texas, including a campus in Greater Houston and a facility in Austin. Alexandria Venture Investments, its venture capital arm, has invested in Texas-based CrossBridge Bio, which is set to be acquired by Eli Lilly for up to $300 million.

BofA downgrades Alexandria Real Estate stock rating on earnings concerns

BofA Securities downgraded Alexandria Real Estate Equities (NYSE:ARE) to Underperform, lowering its price target to $45 from $55. The company reported a $8.40 per share loss and 9.77% revenue decline over the last year, despite a 6.5% dividend yield. BofA cited declining earnings and leasing challenges as reasons for the downgrade. Alexandria's Q3 2026 results showed mixed performance, with revenue exceeding estimates but significant earnings loss due to real estate impairments.

Alexandria Real Estate Equities Inc (ARE) (Q3 2026) Earnings Call Highlights: Record

Alexandria Real Estate Equities Inc (ARE) reported Q3 2026 earnings with record leasing of 1.2M sq ft, strong liquidity at $4.6B, and $1.7B in capital raised. However, same-property NOI declined 6.7% (GAAP) due to lower occupancy (87.1%). The company expects temporary occupancy pressure in early 2027 and recognized $638M in impairments. Management discussed development spending, tenant wind-downs, and disposition strategies during the earnings call.

$AREMedEarnings

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE): Results of Operations and Financial Condition

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 Alexandria Real Estate Equities, Inc. All Rights Reserved . © 2026 Table of Contents September 30, 2026 COMPANY HIGHLIGHTS Page Page Alexandria's Mission and Cluster Model .........................................

Related tickers